VR Adviser

VR Adviser as of Sept. 30, 2022

Portfolio Holdings for VR Adviser

VR Adviser holds 31 positions in its portfolio as reported in the September 2022 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Tricida 14.6 $95M 9.1M 10.48
Aclaris Therapeutics (ACRS) 11.1 $72M 4.6M 15.74
Cogent Biosciences (COGT) 9.3 $60M 4.0M 14.92
Relmada Therapeutics (RLMD) 8.7 $56M 1.5M 37.02
Miragen Therapeutics (VRDN) 6.7 $44M 2.1M 20.51
GH Research Ord Sh (GHRS) 6.0 $39M 3.3M 11.62
Pliant Therapeutics (PLRX) 3.5 $23M 1.1M 20.89
Milestone Pharmaceuticals (MIST) 3.4 $22M 2.4M 9.19
Terns Pharmaceuticals (TERN) 3.4 $22M 3.7M 5.89
Marinus Pharmaceuticals (MRNS) 3.2 $21M 3.2M 6.65
Gossamer Bio (GOSS) 3.2 $21M 1.7M 11.98
Annexon (ANNX) 3.1 $20M 3.2M 6.18
Instil Bio 3.1 $20M 4.1M 4.84
Akouos 2.9 $19M 2.8M 6.76
Dice Therapeutics 2.4 $16M 765k 20.28
Aerovate Therapeutics (AVTE) 2.1 $14M 834k 16.58
LianBio Spons Adr (LIANY) 1.7 $11M 5.4M 2.00
Fulcrum Therapeutics (FULC) 1.5 $9.7M 1.2M 8.09
Inozyme Pharma (INZY) 1.1 $7.3M 2.7M 2.68
Ventyx Biosciences (VTYX) 1.1 $7.3M 208k 34.91
Prometheus Biosciences 1.1 $7.2M 122k 59.01
Savara (SVRA) 1.1 $7.1M 4.6M 1.55
Provention Bio 0.8 $5.0M 1.1M 4.50
Altimmune (ALT) 0.7 $4.7M 369k 12.77
Trevi Therapeutics (TRVI) 0.7 $4.7M 3.1M 1.54
Lyra Therapeutics (LYRA) 0.7 $4.6M 924k 5.01
Immunocore Holdings Ads (IMCR) 0.7 $4.4M 95k 46.94
Atyr Pharma (ATYR) 0.6 $4.2M 1.4M 3.00
Rallybio Corp (RLYB) 0.6 $3.9M 269k 14.47
Affimed Therapeutics B V 0.5 $2.9M 1.4M 2.06
Celldex Therapeutics (CLDX) 0.3 $2.1M 75k 28.11